• 
  • overview
  • philosophy & vision
  • evolution
  • management
    • shareholder letter
    • board of directors
    • company management
  • careers
  • events
• 
  • overview
  • presentations
  • analysts
  • media kit
  • annual reports
• 
  • photodisruptors
    • Ultra Q
    • Super Q
  • photocoagulators
    • Solitaire
    • Integre Duo
    • Integre
  • innovative imaging
    • Eye Cubed
  • SLT photoregeneration
    • Available Outside USA
    • Solo
    • Tango
    • SLT Treatment Information
      • Treatment Guidelines
      • Papers
      • Patient Education
  • education center
  • product demo feedback
• 
• 

OSN Super Site
Ophthalmic Business

Posted on the OSN SuperSite November 12, 2008
ATLANTA — Six-month results of the study of the Ellex 2RT show the laser is safe and effective in the treatment of diabetic macular edema secondary to diabetic retinopathy, according to a press release here.

"Currently, this is the mildest laser therapy to be tested in a clinical setting which has demonstrated a selective and therapeutic effect on the retinal pigment epithelium," John Marshall, PhD, FRCOphth, FRCPath, said in a press release here at the American Academy of Ophthalmology meeting. 

At 6 months, 46% of patients in the study showed a 5% decrease in central macular thickness and 43% of patients showed a two or more line increase in visual acuity, according to the release.